---
created: '2026-02-09T05:54:33.056008Z'
description: Lipid transport protein. The E4 isoform fails to effectively clear Amyloid
  Beta from the brain.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/protein/apoe/
slug: apoe
tags:
- protein
- lipoprotein
- alzheimers
- cholesterol
templateEngineOverride: njk
title: ApoE
type: protein
updated: '2026-02-09T05:54:33.056008Z'
---

{% raw %}
<h1>ApoE</h1>
<h2>Overview</h2>
<p><strong>Apolipoprotein E (ApoE)</strong> is the primary cholesterol carrier in the brain. It is produced mainly by astrocytes.</p>
<p>The <strong>ApoE4</strong> isoform differs from the common ApoE3 by a single amino acid change (Cys112Arg), which alters its structure. This structural change:</p>
<ol>
<li>Reduces its ability to bind and clear Amyloid Beta plaques.</li>
<li>Increases neuroinflammation.</li>
<li>Impairs blood-brain barrier integrity.</li>
</ol>
<!-- NEO4J_CONTENT_START -->
<h2>Relationships</h2>
<h3>Related</h3>
<ul>
<li>→ [[Amyloid_Cascade]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:58.801399'
source: obsidian
</code></pre>
<ul>
<li>→ [[Lipid_Metabolism]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:58.801399'
source: obsidian
</code></pre>
<ul>
<li>→ [[Amyloid_Beta]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:58.801399'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alzheimers_Disease]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:58.801399'
source: obsidian
</code></pre>
<ul>
<li>→ [[Amyloid_Clearance]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:58.801399'
source: obsidian
</code></pre>
<ul>
<li>← [[Alzheimers_Disease]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:30.206636'
source: obsidian
</code></pre>
<ul>
<li>→ [[Lipid_Metabolism]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.742616'
source: obsidian
</code></pre>
<ul>
<li>→ [[LDLR]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.742616'
source: obsidian
</code></pre>
<ul>
<li>→ [[Amyloid_Beta]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.742616'
source: obsidian
</code></pre>
<ul>
<li>→ [[Atherosclerosis]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.742616'
source: obsidian
</code></pre>
<ul>
<li>→ [[Amyloid_Clearance]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.742616'
source: obsidian
</code></pre>
<ul>
<li>→ [[ApoE]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:45.851454'
source: obsidian
</code></pre>
<ul>
<li>← [[Amyloid_Cascade]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.155642'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alzheimers_Disease]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.742616'
source: obsidian
</code></pre>
<!-- NEO4J_CONTENT_END -->
<h2>Relationships</h2>
<h3>Participates in Pathway</h3>
<ul>
<li>→ [[Lipid Metabolism]] (pathway)</li>
<li>→ [[Amyloid Clearance]] (pathway)</li>
</ul>
<h3>Interacts With</h3>
<ul>
<li>→ [[Amyloid Beta]] (protein) - <em>Direct binding</em></li>
<li>→ [[LDLR]] (protein) - <em>Receptor</em></li>
</ul>
<h3>Related Conditions</h3>
<ul>
<li>→ [[Alzheimer's Disease]] (condition)</li>
<li>→ [[Atherosclerosis]] (condition)</li>
</ul>
<h2>References</h2>
<ol>
<li><strong>UniProt</strong>: P02649 (APOE_HUMAN)</li>
<li><strong>Review</strong>: Liu, C. C., et al. (2013). &quot;Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.&quot; <em>Nature Reviews Neurology</em>.</li>
</ol>

{% endraw %}